Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ex-Alere execs plan buyout

This article was originally published in Clinica

Executive Summary

A group led by ex-Alere CEO Ron Zwanziger has made a move to buy the beleaguered company, for an estimated price of $3.82bn. Mr Zwanziger, who resigned unexpectedly from Alere in July, made a Schedule 13D filing with the US Securities and Exchange Commission (SEC) saying the group intends to make an offer of $46 per share for Alere, or possibly higher, and requesting a month-long due diligence period.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts